Usnic acid and its derivatives for pharmaceutical use: a patent review (2000–2017)

References

• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629−661.
   PubMed Web of Science ®Google Scholar
• Zambare VP, Christopher LP. Biopharmaceutical potential of lichens. Pharm Biol. 2012;50:778–798.
   PubMed Web of Science ®Google Scholar
• Bjerke JW, Elvebakk A, Domínguez E, et al. Seasonal trends in usnic acid concentrations of Arctic, alpine and Patagonian populations of the lichen Flavocetraria nivalis. Phytochemistry. 2005;66(3):337–344.
   PubMed Web of Science ®Google Scholar
• Asplund J, Siegenthaler A, Gauslaa Y. Simulated global warming increases usnic acid but reduces perlatolic acid in the mat-forming terricolous lichen Cladonia stellaris. The Lichenologist. 2017;49(3):269–274.
   Web of Science ®Google Scholar
• Abo Khatwa AN, Al Robai AA, Al Jawhari DA. Lichen acids as uncouplers of oxidative phosphorylation of mouse-liver mitochondria. Natural Toxins. 1996;4:96–102.
   PubMedGoogle Scholar
• Francolini I, Norris P, Piozzi A, et al. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother. 2004;48(11):4360–4365.
   PubMed Web of Science ®Google Scholar
• Shtro AA, Zarubaev VV, Luzina OA, et al. Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus. Bioorg Med Chem. 2014;22:6826–6836.
   PubMed Web of Science ®Google Scholar
• Shtro AA, Zarubaev VV, Luzina OA, et al. Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection. Antivir Chem Chemother. 2015;24(3–4):92–98.
   PubMedGoogle Scholar
• Sussmann RAC, Angeli CB, Peres VJ, et al. Intraerythrocytic stages of Plasmodium falciparum biosynthesize vitamin E. FEBS Lett. 2011;585:3985–3991.
   PubMed Web of Science ®Google Scholar
• Vijayakumar CS, Viswanathan S, Kannappa-Reddy M, et al. Anti-inflammatory activity of (+)-usnic acid. Fitoterapia. 2000;71:564–566.
   PubMedGoogle Scholar
• Okuyama E, Umeyama K, Yamazaki M, et al. Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta. Planta Med. 1995;61(2):113–115.
   PubMed Web of Science ®Google Scholar
• Mustafa MR, Mohamad R, Din L, et al. Smooth muscle relaxant activities of compounds isolated from Malaysian medicinal plants on rat aorta and guinea-pig ileum. Phytother Res. 1995;9:555–558.
   Web of Science ®Google Scholar
• Witt RC The effects of selected lichen extracts and purified compounds on the rat heart [ master`s thesis]. Omaha (NE): University of Nebraska; 1996.
   Google Scholar
• Ingolfsdottir K. Usnic acid. Phytochemistry. 2002;61:729–736.
   PubMed Web of Science ®Google Scholar
• Cocchietto M, Skert N, Nimis PL, et al. A review on usnic acid, an interesting natural compound. Naturwissenschaften. 2002;89:137–146.
   PubMed Web of Science ®Google Scholar
• Frankos VH. National Toxicology Program. Washington, DC: Food and Drug Administration, Division of Dietary Supplement Programs; 2005. Available from: http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/UsnicAcid.pdf
   Google Scholar
• Guo L, Shi Q, Fang JL, et al. Review of usnic acid and Usnea barbata toxicity. J Env Sci Heal Part C. 2008;26(4):317–338.
   Web of Science ®Google Scholar
• Han D, Matsumaru K, Rettori D, et al. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol. 2004;67:439–451.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang Z, Qing T, et al. Activation of the Nrf2 signaling pathway in usnic acid-induced toxicity in HepG2 cells. Arch Toxicol. 2017;91(3):1293–1307.
   PubMed Web of Science ®Google Scholar
• Pramyothin P, Janthasoot W, Pongnimitprasert N, et al. Hepatotoxic effect of (+)-usnic acid from Usnea siamensis Wainio in rats, isolated rat hepatocytes and isolated rat liver mitochondria. J Ethnopharmacol. 2004;90:381–387.
   PubMed Web of Science ®Google Scholar
• Dailey RN, Montgomery DL, Ingram JT, et al. Toxicity of the lichen secondary metabolite (+)-usnic acid in domestic sheep. Vet Pathol. 2008;45:19–25.
   PubMed Web of Science ®Google Scholar
• Yokouchi Y, Imaoka M, Niino N, et al. (+)-Usnic acid-induced myocardial toxicity in rats. Toxicol Pathol. 2015;43(3):424–434.
   PubMed Web of Science ®Google Scholar
• Yokouchi Y, Imaoka M, Niino N, et al. Comprehensive evaluation of (+)-usnic acid-induced cardiotoxicity in rats by sequential cross-omics analysis. Toxicol Pathol. 2017;45(4):481–492.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang Z, Wu Y, et al. Endoplasmic reticulum stress and store-operated calcium entry contribute to usnic acid-induced toxicity in hepatic cells. Toxicol Sci. 2015;146(1):116–126.
   PubMed Web of Science ®Google Scholar
• Silva CR, Marinho KS, Silva TD, et al. Teratogenic effect of usnic acid from Cladonia substellata Vainio during organogenesis. Biomed Res Int. 2017;2017:5948936.
   PubMedGoogle Scholar
• Koparal AT, Tüylü BA, Türk H. In-vitro cytotoxic activities of (+)-usnic acid and (-)-usnic acid on V79, A549, and human lymphocyte cells and their non-genotoxicity on human lymphocytes. Nat Prod Res. 2006;20:1300–1307.
   PubMed Web of Science ®Google Scholar
• Prokop’ev IA, Filippov EV, Filippova GV, et al. Pro/antigenotoxic activity of usnic acid enantiomers in Vitro. Bull Exp Biol Med. 2018;164(3):312–315.
   PubMed Web of Science ®Google Scholar
• Arajo AAS, de Melo MGD, Rabelo TK, et al. Review of the biological properties and toxicity of usnic acid. Nat Prod Res. 2015;29(23):2167–2180.
   PubMed Web of Science ®Google Scholar
• Sokolov DN, Luzina OA, Salakhutdinov NF. Usnic acid: preparation, structure, properties and chemical transformations. Russian Chem Rev. 2012;81(8):747–768.
   Web of Science ®Google Scholar
• Luzina OA, Salakhutdinov NF. Biological activity of usnic acid and its derivatives: part 1. Activity against unicellular organisms. Russ J Bioorg Chem. 2016;42:115–132.
   Google Scholar
• Luzina OA, Salakhutdinov NF. Biological activity of usnic acid and its derivatives: part 2. Effects on higher organisms. Molecular and physicochemical aspects. Russ J Bioorg Chem. 2016;42(3):249–268.
   Google Scholar
• Alahmadi AA. Usnic acid biological activity: history, evaluation and usage. Int J Basic Clin Pharmacol. 2017;6:2752–2759.
   Google Scholar
• Martins MC, Silva MC, Silva LR, et al. Usnic acid potassium salt: an alternative for the control of Biomphalaria glabrata. PLoS One. 2014;9(11):e111102.
   PubMed Web of Science ®Google Scholar
• Kristmundsdóttir T, Aradóttir HA, Ingólfsdóttir K, et al. Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J Pharm Pharmacol. 2002;54(11):1447–1452.
   PubMed Web of Science ®Google Scholar
• Nikolic V, Stanković M, Nikolić L, et al. Inclusion complexes with cyclodextrin and usnic acid. J Incl Phenom Macrocycl Chem. 2013;76:173–182.
   Web of Science ®Google Scholar
• Tang Q, Ji H, Tang Ch, et al. Usnic acid and fatty alcohol polyoxyethylene ether complex compound.cn104231255a. 2014.
   Google Scholar
• Zhao Y, Song D, Song T, et al. External preparation for improving transdermal absorption of usnic acid and application of external preparation to promotion of skin injury healing. CN 106943341. 2017.
   Google Scholar
• Qu C, Tu P, Zhao Y, Usnic acid nanometer suspension, and preparation method and use thereof. CN 104398477. 2015.
   Google Scholar
• Luo H, Yamamoto Y, Jeon HS, et al. Production of anti-Helicobacter pylori metabolite by the lichen-forming fungus Nephromopsis pallescens. J Microbiol. 2011;49:66–70.
   PubMed Web of Science ®Google Scholar
• Safak B, Ciftci IH, Ozdemir M, et al. In vitro anti-Helicobacter pylori activity of usnic acid. Phytother Res. 2009;23:955–957.
   PubMed Web of Science ®Google Scholar
• Stankovich S, Pharmaceutical disinfectants based on usninata sodium and medicinal plants and methods of their production. WO 0195900. 2001.
   Google Scholar
• Sun C, Duan C, Zhu L, et al. Application of usnic acid and/or salts thereof. CN 102949298A. 2013.
   Google Scholar
• Davis A, Donoghue G, Eady E, Formulations. US 13505496. 2012.
   Google Scholar
• Eady EA, Fitzgerald DJ, Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt. US 20130316016A1. 2013.
   Google Scholar
• Wichers JW, Rigano LM, Eady EA, et al. Topical formulation containing usnic acid/usnate and dimethyl isosorbide. GB 2481512. 2011.
   Google Scholar
• Abbott SJ, Donoghue G, Eady EA, Usnic acid topical formulation. US 20140057976A1. 2014.
   Google Scholar
• Sun C, Zhai C, Zhu L, et al. Use of usnic acid and derivatives of usnic acid for preparation of medicaments for treating skin diseases caused by malassezia. CN 102526019. 2012.
   Google Scholar
• Pizzoni A, Pizzoni P, New topical compositions comprising usnic acid and their use in therapy. WO 2017134594A1. 2017.
   Google Scholar
• Tang Q, Ji H, Tang C, et al. Liqiid shampoo containing usnic acid and totaxin. CN 104224572. 2014.
   Google Scholar
• Schempp MC, Jocher A, Engel K, et al. Pharmaceutical compositions comprising old man’s beard (Usnea barbata) and St. John’s wort (Hypericum perforatum) and their use. US 20080233145A1. 2008.
   Google Scholar
• Guerra E, Pizzoni A, Pozzi P, Elastomeric composition comprising usnic acid and devices made thereof of coated therewith. EP 3177687.2017.
   Google Scholar
• Pozzi P, Zanasi T, Taurino R, Method for making, by a sol-gel process, catheters including antibacteric coatings based on usnic acid. WO 2012123803. 2012.
   Google Scholar
• Perry NB, Benn MH, Brennan NJ, et al. Antimicrobial, antiviral, and cyctotoxic activity of New Zealand lichens. Lichenologist. 1999;31:627–636.
   Web of Science ®Google Scholar
• Scirpa P, Scambia G, Masciullo V, et al. A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by human papillomavirus. Minerva Ginecol. 1999;51:255–260.
   PubMedGoogle Scholar
• Yamamoto Y, Miura Y, Kimoshita Y, et al. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr virus activation. Chem Pharm Bull. 1995;43:1388–1390.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Miura Y, Kinoshita Y, et al. Epstein-Barr virus activation inhibitor. JP 07–112931. 1995.
   Google Scholar
• Wu J, Tao J, Zhu Y, et al. Application of usnic acid in anti-influenza virus medicaments. CN 101693027A. 2010.
   Google Scholar
• Yu L, Tang L, Liu Z, et al. Application of usnic acid in manufacturing antitumor drugs. CN 103127049. 2013.
   Google Scholar
• Yu L, Zhu H, Application of usnic acid in preparing anti-tumor medicine sensitizer. CN 106924235. 2017.
   Google Scholar
• Kim H, Hur J, Seoun T, et al. Composition for suppressing cancer metastasis comprising flavocetraria cucullata extract, or usnic acid or salt thereof, as active ingredient. KR 1020160034752. 2016.
   Google Scholar
• Song Y, Dai F, Zhai D, et al. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways. Angiogenesis. 2012;15:421–432.
   PubMed Web of Science ®Google Scholar
• Koparal AT. Anti-angiogenic and antiproliferative properties of the lichen substances (-)-usnic acid and vulpinic acid. Z Naturforsch C. 2015;70:159–164.
   PubMed Web of Science ®Google Scholar
• Yi Z, Song Y, Zhang J, et al. Application of usnic acid in preparation of drugs inhibiting angiogenesis. CN 101664401. 2010.
   Google Scholar
• Burlando B, Ranzato E, Volante A, et al. Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds. Planta Med. 2009;75:607–613.
   PubMed Web of Science ®Google Scholar
• Nunes PS, Albuquerque-Júnior RLC, Cavalcante DRR, et al. Collagen-based films containing liposome-loaded usnic acid as dressing for dermal burn healing. J Biomed Biotechnol. 2011;11:1–9.
   Google Scholar
• Jin J, Dong Y, He L. The study on skin wound healing promoting action of sodium usnic acid. Zhong Yao Cai. 2005;28(2):109–111.
   PubMedGoogle Scholar
• Zhang Z, Zheng Y, Li Y, et al. The effects of sodium usnic acid by topical application on skin wound healing in rats. Biomed Pharmacother. 2018;97:587–593.
   PubMed Web of Science ®Google Scholar
• Davies JE, Waters B, Saxena G, Method for inhibiting eukaryotic protein kinases US 6455270B1. 2002.
   Google Scholar
• Kim C, Composition for skin whitening containing compound with an effect of suppressing melanogenesis without side effects KR 1020100061978. 2010.
   Google Scholar
• Lee SH, Pharmaceutical composition for preventing or treating bone related diseases. KR 1020150100331. 2015.
   Google Scholar
• Cho HS, Lee SK, Lee SH, Composition for inhibiting growth of body hair comprising usnic acid as effective ingredient. KR 101511446. 2015.
   Google Scholar
• Lee HK, Yim JH, Kim IC, et al. Stereocaulon alpinum extract having a blood sugar reducing effect and usnic acid derivative isolated therefrom. KR 1020090049950. 2009.
   Google Scholar
• Malamas MS, Sredy J, Gunawan I. New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties. J Med Chem. 2000;43(5):995–1010.
   PubMed Web of Science ®Google Scholar
• James T, Lind K, Du Z, et al. Inhibition of RNA function. US 2003/0229082A1. 2003.
   Google Scholar
• Becker OB, Danilenko VN, Luzina OA, et al. Aminotiazole derivatives of usnic acid as new antituberculous agents. RF 2483722С1. 2013.
   Google Scholar
• Verotta L, Bruno M, Trucchi B, et al. Dibenzofuran derivatives with antibacterial and wound-healing activity. WO 2013189950A1. 2013.
   Google Scholar
• Marshak A, Barry GT, Craig LC. Antibiotic compound isolated from the lichen Ramalina reticulate. Science. 1947;106:394–395.
   PubMed Web of Science ®Google Scholar
• Klosa J. Chemische Konstitution und antibiotische Wirkung der Flechtenstoffe. Pharmazie. 1953;8:435–442.
   PubMedGoogle Scholar
• Marshak A, Kuschner M. The action of streptomycin and usnic acid on the development of tuberculosis in guinea pigs. Public Health Rep (1896-1970). 1950;48:131–144. 65(5), Tuberculosis Control Issue.
   Google Scholar
• Ingolfsdottir K, Chung G, Skulason V, et al. Antimycobacterial activity of lichen metabolites in vitro. E J Pharm Sci. 1998;6:141–144.
   PubMed Web of Science ®Google Scholar
• Lira MCB, Siqueira-Moura MP, Rolim-Santos HML, et al. In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation. J Liposome Res. 2009;19(1):49–58.
   PubMed Web of Science ®Google Scholar
• Ramos DF, Da Silva PEA. Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria. Pharm Biol. 2010;48(3):260–263.
   PubMed Web of Science ®Google Scholar
• Patiala J, Brander EL. Usnic acid, dihydrostreptomycin, and their combination; therapeutic effect in guinea-pig tuberculosis as revealed by the omental index. Ann Med Exp Biol Fenn. 1954;32(3):282–286.
   PubMedGoogle Scholar
• Ferraz-Carvalho RS, Pereira MA, Linhares LA, et al. Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates. Memórias Do Instituto Oswaldo Cruz. 2016;111(5):330–334.
   PubMed Web of Science ®Google Scholar
• Becker OB, Danilenko VN, Luzina OA, et al. Preparing quaternised usnic acid derivatives and their biological properties. RF 2477127С1. 2013.
   Google Scholar
• Becker ОB, Danilenko VN, Luzina OA, et al. Aminothiazole derivatives of usnic acid as new antituberculous agents. RF 2483722. 2013.
   Google Scholar
• Becker ОB, Danilenko VN, Luzina OA, et al. Furidenfuranone derivatives of usnic acid as new antituberculous agents. RF 2533707. 2014.
   Google Scholar
• Sokolov DN, Luzina OA, Polovinka MP, et al. Usnic acid and its oxidized derivative as inhibitors of reproduction of the influenza virus. RF 2464033S1. 2012.
   Google Scholar
• Verotta L, Monti D, Compounds with antimalarial activity. WO 2010034512A1. 2010.
   Google Scholar
• Pokrovsky AG, Pokrovsky MA, Sokolov DN, et al. Usnic acid derivatives antineoplastic agents. RF 2536873. 2014.
   Google Scholar
• Narlawar R, Kassiou M, Felczykowska A, et al. New compounds derivatives of usnic acid, method for producing them, pharmaceutical composition and application. PL 413596 (A1). 2017.
   Google Scholar
• Pommier Y, Leo E, Zhang H, et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010;17:421–433.
   PubMed Web of Science ®Google Scholar
• Comeaux EQ, van Waardenburg RC. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target. Drug Metab Rev. 2014;46:494–507.
   PubMed Web of Science ®Google Scholar
• Zakharenko A, Lebedeva N, Luzina O, et al. Means for inhibiting the human tyrosyl-DNA phosphodiesterase 1 enzyme. RF 2605329. 2016.
   Google Scholar
• Zakharenko A, Luzina O, Sokolov D, et al. Hydrazine thiazole derivatives of usnic acid with inhibitory action towards human tyrosyl-DNA-phosphodiesterase 1 enzyme. RF 2612256. 2017.
   Google Scholar
• Luzina O, Zakharenko A, Sokolov D, et al. 2-Acetyl-6-(2-(2-(4-brombenzylidene)hydrazinyl)thiazol-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldiobenzo[b,d]furan-1(9bh)-oh, with inhibiting action on human tyrosyl-DNA-phosphodiesterase 1. RF 2627764. 2017.
   Google Scholar
• Zakharenko AL, Sokolov DN, Luzina OA, et al. A means for inhibiting the enzyme of poly (ADP-ribose) polymerase 1 human. RF 2500675. 2013.
   Google Scholar
• Lee HK, Yim JH, Kim IC, et al. Stereocaulon alpinum extract having a blood sugar reducing effect and usnic acid derivative isolated therefrom. KR 1020070116333. 2009.
   Google Scholar
• Barton DHR, Deflorin M, Edwards OE. The synthesis of usnic acid. J Chem Soc. 1953;108:530–534.
   Google Scholar
• Zakharenko A, Luzina O, Koval O, et al. Tyrosyl-DNA phosphodiesterase 1 inhibitors: usnic acid enamines enhance the cytotoxic effect of camptothecin. J Nat Prod. 2016;79:2961–2967.
   PubMed Web of Science ®Google Scholar
• Zakharenko AL, Luzina OA, Sokolov DN, et al. Usnic acid derivatives are effective inhibitors of tyrosyl-DNA phosphodiesterase 1. Russ J Bioorg Chem. 2017;43:84–90.
   Google Scholar